Search stocks

Find any stock by ticker or company name

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

О нас

Контакты

[email protected]

Мы в соцсетях

Instagram
Telegram
LinkedIn

Все права защищены.

Условия использования

Главная
Избранное
Рынки
Календарь
Скринер
Новости
О нас

XTNT - Xtant Medical Holdings, Inc.... | Finranks

Home

/

XTNT

X

Xtant Medical Holdings, Inc. (XTNT)

ASE – Цена в реальном времени. Валюта: USD

0.30

-0.02 (-6.09%)

Рынок открыт: Aug 12, 2026, 12:27 PM EDT

0.32

+0.00 (0.97%)

Предыдущая сессия: Aug 11, 2026, 7:42 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call Transcript

Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call Transcript

Xtant Medical Reports Second Quarter 2026 Financial Results

Xtant Medical Reports Second Quarter 2026 Financial Results

Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures Company to host investor conference call and webcast today, August 11 th, at 8:30am ET BELGRADE, Mont., Aug. 11, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the second quarter ended June 30, 2026.

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026

BELGRADE, Mont., Aug. 6, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the second quarter ended June 30, 2026, before the start of trading on Tuesday, August 11, 2026.

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

BELGRADE, Mont., Aug. 4, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that Sean Browne, CEO, Scott Neils, CFO, and Mark Schallenberger, COO, will be participating in the Canaccord Genuity 46th Annual Growth Conference, which is being held August 11-13, 2026, in Boston.

Видео

No Data

There is no data to display

Пресс-релизы

Xtant Medical Reports Second Quarter 2026 Financial Results

Xtant Medical Reports Second Quarter 2026 Financial Results

Launched Trivium™ Shaped, an extension of its Trivium line of premium, next-generation demineralized bone matrix allograft for bone grafting procedures Company to host investor conference call and webcast today, August 11 th, at 8:30am ET BELGRADE, Mont., Aug. 11, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today reported financial and operating results for the second quarter ended June 30, 2026.

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference

BELGRADE, Mont., Aug. 4, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that Sean Browne, CEO, Scott Neils, CFO, and Mark Schallenberger, COO, will be participating in the Canaccord Genuity 46th Annual Growth Conference, which is being held August 11-13, 2026, in Boston.